Accelerate Diagnostics, Inc. is in vitro diagnostics company engaged in providing solutions for the global challenges of antibiotic resistance and sepsis. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.
Company codeAXDX
Company nameAccelerate Diagnostics Inc
IPO dateOct 27, 1993
Founded at2012
CEOMr. John (Jack) Phillips
Number of employees107
Security typeOrdinary Share
Fiscal year-endOct 27
Address3950 S Country Club Rd Ste 470 Bldg 3-307
CityDENVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80203
Phone13038638088
Websitehttps://acceleratediagnostics.com/
Company codeAXDX
IPO dateOct 27, 1993
Founded at2012
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data